Roundtable Discussion; The Future of Mineral Sands. Watch the video here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
Since IPO I don’t think a significant shareholder has sold a single share, I’m surprised anyone would the potential is huge
Someone comes in at the end of the day and takes advantage of the idiots that gave their shares away cheap today, I’ve never been lucky enough to get so many at once HL made me work hard to get my first 75k shares
No selling just the adjustments in Holdings since the recent fundraising
Should get the last couple hospitals to take the total to 10 for the early access
https://www.linkedin.com/posts/lunglife-ai_42nd-edrn-steering-committee-meeting-activity-7186308919277887488-9EPR?utm_source=share&utm_medium=member_ios
Extract from an article in today's Shares magazine by AJ Bell, on the role of AI in medicine:
AIM-quoted LungLife AI (LLAI:AIM) is a diagnostic company focused on the early detection of lung cancer.
The company is developing a test that pairs a simple blood draw with artificial intelligence to provide clinicians and patients the information they need to make informed decisions about the management of lung nodules and lung cancer.
In January 2024 the results of a clinical study demonstrated a strong PPV (positive predictive value) of 81% in discriminating cancerous lung nodules in patients with smaller nodules less than 15 millimetres.
These types of nodules present the greatest challenge for physicians in detecting cancers. Current standard of care generates a PPV of 60% which leads to material delays in diagnosis of deadly cancers.
Can’t wait to hear about the next-12 months
Since IPO I can only remember l occasion when they got something wrong- they thought the reimbursement would take 6 months longer to get and they expected it to be $1000 not $2030
I forgive them for getting that wrong lol
It’s at 16:00
Friday 5 April
Full Year results for the year ending 31st December 2023
Hopefully by then we’ll be doing 100 tests per week we already have the equipment and staff for that many tests, revenue of over $10 million
Cash runway until mid 25..
Strengthens balance sheet ahead of working further towards commercial deals.
“The net proceeds of the Fundraising, along with the Company's existing cash resources, are expected to be utilised to establish the commercial proof of concept of the Company's LungLB® test”
You can still buy less than the fund raise..
Hopefully this will start to go north
Https://neogenomics.com/invisionfirstr-lung
I think our test would fit into the offering these have, I wonder how much a $2 billion company would pay for the missing product they really need
Thought I’d catch the falling knife so I just bought some for 2 of my accounts
And I bet there’s a good number of people holding a lot more than £20k worth each, the supply is really tight
It would only take 100 retail investors buying just 46,000 shares each, less than £20k worth to leave nothing left, so imo buying now is the sensible move GL
Your timing was much better than mine David, When I started buying this I was paying over a quid and was lucky if I could get 2000 shares at a time, it was really difficult and I had to complain to HL for nearly a year to get them to list it.
I think the current shareholders will fund the growth, 82% held by significant shareholders and these guys are not going to let newcomers jump in at discounted prices imo.
I’m ready to buy more if they need funding, I think you’ll need to be holding this one to play in that round
They already have the staff and equipment to do £10 million revenue (95 tests per week)
Followed this for some time and no doubt it could be a gamechanger with a much higher SP to come. FY results will come out in February but the investment risk is that additional funding needed would mean dilution which would be at a heavily discounted price based on current AIM market conditions. Bought 10k shares to start with and will add when possible.
Im still buying at 46p ..ludicrously under valued given the science, institutional holdings, and BOD members.